Portfolio

UU Invest AB invests in cutting-edge expertise and ideas with the capacity to contribute to challenges that society faces. We invest in companies and projects in all three of Uppsala University’s areas of science: humanities and social sciences, medicine and pharmacy, as well as technology and science. Here you can read more about some of our portfolio companies. If you want to know more about how we work to increase the opportunity for start-up companies to take their research and ideas further and how you as a researcher can benefit from our offer, please contact us.

  • Show all
  • Exits
  • Hum/Soc Sci
  • Life Science
  • Technology
Life Science
SampleFacts
Life Science
VOC Diagnostics
Life Science
Artroa
Life Science
SGPTH Life Sciences
Life Science
VivoLogica
Life Science
Readily
Life Science
RX Dynamics
Life Science
MyCural Therapeutics
Hum/Soc Sci
Mind Intelligence Lab
Technology
Optima Planta
Technology
Scaleout
Technology
Storesprint
Life Science
Rarity Bioscience
Life Science
Disruptive Pharma
Life Science
MM18 Medical
Hum/Soc Sci
ZEEDS App
Technology
Stardots
Technology
Drupps
Life Science
Ultimovacs
Technology
Diplocs
Life Science
Symptoms
Life Science
Oncodia
Life Science
Olink Proteomics
Exits
Life Science
Ilya Pharma
Hum/Soc Sci
Disir
Exits
Astrego
Exits
Technology
Leafymade
Life Science
Cadess
Technology
ETA Scale
Life Science
Genagon
Technology
Boardie
Life Science
Dicot
Life Science
Emplicure
Life Science
Cray Innovation
Life Science
RedHot Diagnostics
Technology
Green Cache
Exits
Life Science
Immuneed
Technology
Ascilion
Technology
Psilox
Technology
Disruptive Materials
Technology
Ngenic
Technology
Antisnore
Exits
Hum/Soc Sci
EduQuality
Technology
Airwatergreen
Hum/Soc Sci
Acabo Games
Exits
Hum/Soc Sci
Uppstuk AB
Exits
Life Science
Ossdsign
Life Science
Gradientech
Hum/Soc Sci
Convertus
Life Science
Q-linea
Exits
Life Science
Halo Genomics
Exits
Technology
Imint
Exits
Life Science
Beactica
Technology
Current Power
Life Science
Atlas Antibodies
Exits
Life Science
Arocell Diagnostic
Exits
Technology
Acumem
Exits
Hum/Soc Sci
Academicum
Technology
ÅAC Clyde Space
Exits
Rolling Optics
Exits
Technology
Primateria
Exits
Life Science
Bioarctic Biociences
Exits
Technology
Rotundus
Exits
Technology
Solibro
Exits
Life Science
Sensidose
Exits
Technology
Vertical Wind
Technology
Chromogenics
Exits
Technology
VIOGARD AB
Exits
Life Science
Strike Pharma
Technology
PapersHive
Life Science
Navinci

Currently

Show:

Collaboration graphic visual. Teamwork graphics.

From Research to Business – Collaboration between UU Innovation and UU Invest shorten your time to market

UU Invest hosts your project so that you can establish necessary agreements with collaborative partners, hire key personnel to investigate or develop the concept, and also assist ‘hands on’ in negotiations and strategic work.

Ida-Maria Sintorn portrait

SimSearch – New powerful tool in the work with biological microscope images

Ida-Maria Sintorn, along with her colleagues in the SimSearch project, is developing new technology for image processing of microscopic images. The focus is to make it easier, faster, and safer for researchers to extract relevant information from large amounts of data while retaining control over their own data.

CEO of HyEnGen Oscar Verho

HyEnGen – Pioneering Research for Sustainable Energy Production

Oscar Verho and his research network are focused on creating more efficient ways to produce fuels from water. The path involves advanced interdisciplinary development and a sustainable, efficient electrode with the potential to make green hydrogen production more cost-effective.

Matteo, en av Paperhives grundare.

AI accelerates evidence-based clinical decisions

PapersHive is one of UU Invest’s 55 portfolio companies. With an AI-based search technology, the company collects information from all medical databases in one place. This saves both time and money for pharmaceutical companies, CROs and medical technology companies.

Graphic footage with text that describes that venturechallenge 2023 is now closed.

Applications for VentureChallenge 2023 are now closed

Applications for VentureChallenge 2023 are now closed. A new call for applications will open again in the first quarter of 2024.

VentureChallenge text

VentureChallenge 2023

Up to 500,000 SEK for your research-based business idea. UU Invest, in collaboration with UU Innovation, is now conducting a call for start-up capital of up to 500,000 SEK for your research-based business idea.

Tv. Gunilla Lundmark
Verkställande direktör UU Invest

Th. Malin Graffner Nordberg
Chef vid Uppsala universitet Innovation (UU Innovation)

Foto Mikael Wallerstedt

Successful collaboration delivers results

Meet Gunilla Lundmark, CEO of UU Invest, and Malin Graffner Nordberg, Head of UU Innovation. With different roles and expertise, they work towards the same overall goal – to contribute to Uppsala University’s efforts to take research forward and utilise knowledge in society.

Linus Bosaeus, VD för Rarity Bioscience

Precisionsdiagnostik i fokus för Rarity Bioscience

Ulf Landegren och hans forskningsgrupp ligger bakom banbrytande forskning som lett till nya innovationer som framgångsrikt förvaltats och utvecklats i en rad olika bolag. Rarity Bioscience med vd Linus Bosaeus är ett av de senaste i raden.